Lobo Genetics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5288 General Rd Unit 8, Mississauga, Ont...Phone Number
(416) 871-4250Website
www.lobogene.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Lobo Genetics
Lobo is a Toronto-based arm's length private corporation incorporated on June 11, 2018 under the CBCA. Lobo is a personalized genetics company with a direct-to-consumer (DTC) platform currently being used in both the psychedelics and cannabis space to provide personalized insights into an individual's response to hallucinogenic and psychoactive drugs.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lobo Genetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Lobo Genetics launches new products
Congratulate Masked Content for being promoted to Masked Content at Lobo Genetics
Click to see if Lobo Genetics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Lobo Genetics has new funding data
Check if Lobo Genetics has recently received funding, and reach out quickly before it becomes old news!
Lobo Genetics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Lobo Genetics recently announced quarterly report
Check out if Lobo Genetics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Lobo Genetics
Compare insights from companies similar to Lobo Genetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lobo Genetics
<$5M
11-50
Private
-
2018
N/A
Company Profile Activity
Activity Insights
Lobo Genetics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Lobo Genetics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Lobo Genetics.
Lobo Genetics Tech Stack
A closer look at the technologies used by Lobo Genetics
Lobo Genetics News & Media
Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
Genetic Screening Platform Technology and Data to Strengthen Entheon's Psychedelic-Assisted ProtocolsVancouver, British Columbia--(Newsfile Corp. - July 30, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company") is pleased to announce that the Company completed its acquisition of Lobo Genetics Inc. ("Lobo"), a personalized genetics company with a direct-to-consumer platform currently being used in both the psychedelics and cannabis spaces to provideEntheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.
Genetic Screening Platform Technology and Data to Strengthen Entheon's Psychedelic-Assisted ProtocolsVancouver, British Columbia--(Newsfile Corp. - June 16, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company") is pleased to announce that the Company has entered into a definitive agreement dated June 15, 2021 (the "Agreement") with Lobo Genetics Inc. ("Lobo"), and 13089363 Canada Inc. ("Subco"), a wholly-owned subsidiary of Entheon. Pursuant to theLobo Genetics and Alcanna Bring Genetic Testing to Alberta Cannabis Consumers
TORONTO, March 14, 2019 (GLOBE NEWSWIRE) -- Lobo Genetics Inc. (“Lobo”), a leading cannabis healthcare technology company and Alcanna Inc. (“Alcanna”) (TSX: CLIQ), owner of Nova Cannabis and one of the largest private sector retailers of alcohol in North America, are pleased to announce an industry-first partnership that brings direct-to-consumer cannabis genetic testing to Alcanna’s Nova Cannabis stores.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lobo Genetics
Sign Up For FreeTo access detailed company insights
Lobo is a Toronto-based arm's length private corporation incorporated on June 11, 2018 under the CBCA. Lobo is a personalized genetics company with a direct-to-consumer (DTC) platform currently being used in both the psychedelics and cannabis space to provide personalized insights into an individual's response to hallucinogenic and psychoactive dru... Read More
